Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Tuberculosis
- Vol. 101, 164-173
Abstract
No abstract availableKeywords
Funding Information
- Govt. of India (BT/MB/VGCP-19)
- National Institute of Immunology
This publication has 38 references indexed in Scilit:
- Massive gene acquisitions in Mycobacterium indicus pranii provide a perspective on mycobacterial evolutionNucleic Acids Research, 2012
- IL-17 and Th17 cells in tuberculosisCytokine & Growth Factor Reviews, 2010
- Enhanced and Enduring Protection against Tuberculosis by Recombinant BCG-Ag85C and Its Association with Modulation of Cytokine Profile in LungPLOS ONE, 2008
- Influence ofMycobacterium bovisBCG Vaccination on Cellular Immune Response of Guinea Pigs Challenged withMycobacterium tuberculosisClinical and Vaccine Immunology, 2008
- Tumor Necrosis Factor Signaling Mediates Resistance to Mycobacteria by Inhibiting Bacterial Growth and Macrophage DeathImmunity, 2008
- Cytokine Profiles in Primary and Secondary Pulmonary Granulomas of Guinea Pigs with TuberculosisAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populationsEuropean Journal of Immunology, 2007
- Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing CellsJournal of Virology, 2007
- Interleukin-12 and tuberculosis: an old story revisitedCurrent Opinion in Immunology, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007